Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Recruiting now · Phase 3

Conditions studied: Major Depressive Disorder

In brief

This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.

Key facts

Study ID

NCT06966401

Run by

Neurocrine Biosciences

People needed

850

Starts

2025-04-16

Expected to finish

2030-05-01

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Neurocrine Clinical Site — Boston, Massachusetts, United States (enrolling)
• Neurocrine Clinical Site — Huntsville, Alabama, United States (enrolling)
• Neurocrine Clinical Site — Glendale, California, United States (enrolling)
• Neurocrine Clinical Site — Bryant, Arkansas, United States (enrolling)
• Neurocrine Clinical Site — Little Rock, Arkansas, United States (enrolling)
• Neurocrine Clinical Site — Orange, California, United States (enrolling)
• Neurocrine Clinical Site — Pico Rivera, California, United States (enrolling)
• Neurocrine Clinical Site — San Diego, California, United States (enrolling)
• Neurocrine Clinical Site — Los Angeles, California, United States (enrolling)
• Neurocrine Clinical Site — San Jose, California, United States (enrolling)
• Neurocrine Clinical Site — Oceanside, California, United States (enrolling)
• Neurocrine Clinical Site — Cromwell, Connecticut, United States (enrolling)
• Neurocrine Clinical Site — Farmington, Connecticut, United States (enrolling)
• Neurocrine Clinical Site — Hollywood, Florida, United States (enrolling)
• Neurocrine Clinical Site — Maitland, Florida, United States (enrolling)
• Neurocrine Clinical Site — Maitland, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami Gardens, Florida, United States (enrolling)
• Neurocrine Clinical Site — San Francisco, California, United States (enrolling)
• Neurocrine Clinical Site — Palm Bay, Florida, United States (enrolling)
• Neurocrine Clinical Site — Tampa, Florida, United States (enrolling)
• Neurocrine Clinical Site — Tampa, Florida, United States (enrolling)
• Neurocrine Clinical Site — Atlanta, Georgia, United States (enrolling)
• Neurocrine Clinical Site — Gaithersburg, Maryland, United States (enrolling)
• Neurocrine Clinical Site — Watertown, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.